KYMERA THERAPEUTICS, INC. (KYMR) Free cash flow 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$234.3MFY2025 · since FY2019: $17.4M → -$234.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$234.3M | -13.0% |
| FY2024 | -$207.3M | -51.0% |
| FY2023 | -$137.3M | +11.9% |
| FY2022 | -$155.9M | -19.4% |
| FY2021 | -$130.5M | -265.2% |
| FY2020 | $79.0M | +354.9% |
| FY2019 | $17.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYMR financial trends
KYMR RevenueKYMR Net incomeKYMR Net marginKYMR Gross profitKYMR Gross marginKYMR Operating incomeKYMR Operating marginKYMR Operating cash flowKYMR Capital expendituresKYMR Return on equityKYMR Stock buybacksKYMR Dividends paidKYMR Total assetsKYMR Total liabilitiesKYMR Shareholders’ equityKYMR overview →